High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2
B. Vanhove, O. Duvaux, J. Rousse, P.-J. Royer, G. Evanno, C. Ciron, E. Lheriteau, L. Vacher, N. Gervois, R. Oger, Y. Jacques, S. Conchon, A. Salama, R. Duchi, I. Lagutina, , J.-P. Soulillou
This paper describes the development of glyco-humanized swine polyclonal antibodies (GH-pAb) that neutralize SARS-CoV-2 with high potency and safety, and suggests clinical evaluation of the antibody XAV-19.
bioRxiv · Jul 25, 2020Immunology